Differential Diagnosis of Primary and Secondary Hyperparathyroidism Caused by Vitamin D Deficiency

Abstract

Causes of secondary increase of parathyroid hormone, especially vitamin D deficiency, can significantly interfere with the diagnosis of hyperparathyroidism. The most difficult situation occurs when moderate increase in parathyroid hormone coincides with slightly elevated or normal levels of calcium in the blood serum. Given the predominantly surgical way of treating patients with primary hyperparathyroidism, it is important to distinguish vitamin D deficiency and indeed primary hyperparathyroidism. Objective: to develop a method for the differentiation of primary and secondary hyperparathyroidism associated with vitamin D deficiency. Materials and methods. We provide reliable, standardized protocol for short treatment with ergocalciferol (3000 IU a day for 45–50 days) to remove the effects of vitamin D deficiency on laboratory criteria of primary hyperparathyroidism. Reduction of more than 30 % and normalization of serum parathyroid hormone without serum calcium increase exclude primary hyperparathyroidism and the need for surgery. Results. We have studied a clinical group of 72 selected patients who meet the criteria of moderately elevated parathyroid hormone, normal or slightly increased levels of calcium, with vitamin D deficiency, absence of chronic kidney diseases or malabsorption. After 45–50 days of vitamin D intake, the normalization of parathyroid hormone without hypercalcaemia was observed in 61 patients (85 %). They were excluded from the clinical group of primary hyperparathyroidism. Hereafter, we did not observe cases of primary hyperparathyroidism progression in this group. The rest of the patients (10 of 72) were successfully operated for primary hyperparathyroidism, except one patient which refused surgery and is still under observation. Conclusions. Short ergocalciferol treatment can be a valuable and reliable clinical method to differentiate isolated vitamin D deficiency and asymptomatic primary hyperparathyroidism combined with a lack of vitamin D.

Authors and Affiliations

S. M. Cherenko, H. V. Bandura

Keywords

Related Articles

Pseudothyroid dysfunction in clinical practice: how to avoid diagnostic errors

The lecture provides modern information about euthyroid sick syndrome (non-thyroidal illness syndrome). Data are presented on the possible causes and mechanisms of thyroid homeostasis disorders under various physiologica...

Statistical Determination of the Boundaries of Critical Ischemia in Patients with Diabetic Foot Syndrome

Using Cox regression we have analyzed dependence of the probability of amputation and death in patients with critical lower limb ischemia in diabetic foot syndrome on the initial value of the partial pressure of oxygen (...

Violations of the System of Lipid Peroxidation in Type 2 Diabetes Mellitus (Literature Review)

The review presents the data on the current state of the problem of diabetes mellitus type 2 and the role of oxidative stress. Over the last decade, the number of patients with diabetes mellitus has increased by more tha...

Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation)

The article provides an overview of data on the clinical efficacy of glimepiride (Amaryl®) in diabetes mellitus type 2: there are described the effect of glimepiride on insulin resistance, body weight, its antiatherogeni...

The Case of Combined Empty Sella Syndrome and Adrenal Tumor with Pseudo Precocious Puberty in 4 Years Old Boy

It is described a case of combined empty sella syndrome and adrenal tumor with pseudo precocious puberty in 4 years old boy. Before the operative treatment of adrenal tumor pseudo precocious puberty was determined, then...

Download PDF file
  • EP ID EP219489
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

S. M. Cherenko, H. V. Bandura (2015). Differential Diagnosis of Primary and Secondary Hyperparathyroidism Caused by Vitamin D Deficiency. Міжнародний ендокринологічний журнал, 5(69), 19-23. https://europub.co.uk/articles/-A-219489